Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
Merck
Harvard Business School
Dow
Medtronic

Last Updated: January 16, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Fispemifene


Email this page to a colleague

« Back to Dashboard

What is the drug development status for Fispemifene?

Fispemifene is an investigational drug.

There have been 4 clinical trials for Fispemifene. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2015.

The most common disease conditions in clinical trials are Hypogonadism, Erectile Dysfunction, and Pulmonary Disease, Chronic Obstructive. The leading clinical trial sponsors are QuatRx Pharmaceuticals Company, Hormos Medical, and NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.).

There are forty-one US patents protecting this investigational drug and nine hundred and eighty-four international patents.

Recent Clinical Trials for Fispemifene
TitleSponsorPhase
Safety and Efficacy Study of Oral Fispemifene for the Treatment of Sexual Dysfunction in Hypogonadal MenNexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.)Phase 2
Efficacy and Safety of Fispemifene in the Treatment of Hypogonadal Men With Chronic Obstructive Pulmonary Disease That Are on Oral Glucocorticoid TherapyQuatRx Pharmaceuticals CompanyPhase 2
Efficacy and Safety Evaluating Fispemifene in the Treatment of Hypogonadal Men With Erectile Dysfunction Unresponsive to PDE5 InhibitorsHormos MedicalPhase 2

See all Fispemifene clinical trials

Clinical Trial Summary for Fispemifene

Top disease conditions for Fispemifene
Top clinical trial sponsors for Fispemifene

See all Fispemifene clinical trials

US Patents for Fispemifene

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Fispemifene ⤷  Sign up for a Free Trial Selective androgen receptor modulator and methods of use thereof UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (Knoxville, TN) ⤷  Sign up for a Free Trial
Fispemifene ⤷  Sign up for a Free Trial Methods for immunomodulation of cancer and infectious disease therapy The Regents of the University of California (Oakland, CA) ⤷  Sign up for a Free Trial
Fispemifene ⤷  Sign up for a Free Trial Molecules for administration to ROS1 mutant cancer cells IGNYTA, INC. (San Diego, CA) NERVIANO MEDICAL SCIENCES S.R.L. (Nerviano, IT) ⤷  Sign up for a Free Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Fispemifene

Drugname Country Document Number Estimated Expiration Related US Patent
Fispemifene Argentina AR061980 2024-06-07 ⤷  Sign up for a Free Trial
Fispemifene Argentina AR062536 2024-06-07 ⤷  Sign up for a Free Trial
Fispemifene Austria AT344233 2020-08-24 ⤷  Sign up for a Free Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
Merck
Harvard Business School
Dow
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.